Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
On March 17th, Tebio had 1 large block transaction at a discount of 19.28%, with a total transaction amount of 31.9051 million yuan.
Securities Star News: On March 17, Tech-Bio Biologicals had a block trade. The trading data is as follows:
The block trade was executed at a price of 56.27 yuan, a discount of 19.28% compared to the closing price on that day. The trade involved 567,000 shares, with a total transaction amount of 31.9051 million yuan. The buyer’s brokerage was GF Securities Co., Ltd. Xiamen Donghuang Road Securities Branch, and the seller’s brokerage was GF Securities Co., Ltd. Jinjiang Chongde Road Securities Branch.
In the past three months, this stock has had a total of 8 block trades, totaling 133,000 lots, with 1 trade at a discount. There have been no recent unlockings of restricted shares.
As of the close on March 17, 2026, Tech-Bio Biologicals (688278) closed at 69.71 yuan, down 0.88%. The turnover rate was 0.41%, with a trading volume of 16,900 lots and a transaction amount of 119 million yuan.
In the past 90 days, three institutions have issued ratings for this stock, all recommending a buy. The average target price from these institutions over the past 90 days is 88.47 yuan.
The above content is compiled from public information by Securities Star, generated by AI algorithm (Wangxin Algorithm Backup No. 310104345710301240019), and does not constitute investment advice.